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To the Editor,
In a recently published survey of 100 liver centers,
Breitenstein et al. [1] reported that on a global scale, (1) the
average minimal remnant liver volume for resection is 25%
(range = 15-40%) for normal liver parenchyma and 50%
(range = 25–90%) for cirrhotic livers, (2) portal vein
occlusion is employed in 89% of the centers for purposes
of augmenting liver volume before surgery, and that (3)
38% of the centers employed liver function tests as part of
their clinical routine, of which 76% used the ICG clearance
test.
The interesting survey provoked a few issues that we
feel obliged to address. The authors contend that ‘‘below a
certain volume, a remnant liver cannot sustain metabolic,
synthetic, and detoxifying functions’’ [1]—a statement that
is unequivocal and uncontested. However, it should be born
in mind that liver volume is not a directly proportional
measure of liver function. We have demonstrated a few
fundamental aspects of the volume-function relationship
that support this notion: (i) Whereas liver function corre-
lates with volume in uncompromised livers [2], there is
signiﬁcantly less correlation between liver volume and
function in patients with coexisting parenchymal liver
disease [3, 4]. (ii) This discrepancy also applies to the
regenerating liver [3]. (iii) The liver often exhibits func-
tional heterogeneity [3]. These ﬁndings have been cor-
roborated to some extent by others [5]. Consequently, a
marginal remnant liver volume (e.g., 25% for cirrhotic
livers [1]) may translate to functional deﬁciencies follow-
ing resection and hence predisposes the organ to the
‘‘small-for-size’’ or, rather, the ‘‘small-for-function’’ syn-
drome. Likewise, allowing the organ to regenerate to a
predetermined volume before resection bears comparable
implications and strongly pleads for the use of dynamic
liver function tests rather than CT volumetry as the gold
standard, particularly for borderline surgical decisions.
We emphasize speciﬁcally the use of quantitative
dynamic liver function tests [i.e., ICG clearance,
99mTc-
mebrofenin hepatobiliary scintigraphy (HBS) [2–4], gal-
actose elimination capacity (GEC) [5], and
99mTc-labeled
galactosyl human serum albumin scintigraphy (GSAS)]
inasmuch as conventional liver function tests such as pro-
thrombin time, serum bilirubin, and the Child-Pugh score
are relatively insensitive and are thus lagging indicators for
determining whether a liver resection can be safely per-
formed. It is well known that there are notable discrepan-
cies between the above-mentioned dynamic liver function
tests in the assessment of liver function. In our patient
population, ICG and
99mTc-mebrofenin uptake exhibited
similar pharmacokinetics in regenerating rat livers (that
also corresponded well to the extent of hepatic damage),
whereas the GSAS and GEC tests displayed an underesti-
mation and an overestimation, respectively, of liver func-
tion in comparison to ICG and
99mTc-mebrofenin uptake
(unpublished). This is because liver function encompasses
a broad spectrum of processes, ranging from uptake, syn-
thesis, biotransformation, and systemic and canalicular
M. Heger (&)  W. de Graaf  T. M. van Gulik
Department of Experimental Surgery, Academic Medical Center,
University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam,
The Netherlands
e-mail: M.Heger@amc.uva.nl
R. J. Bennink
Department of Nuclear Medicine, Academic Medical Center,
University of Amsterdam, Amsterdam, The Netherlands
U. Beuers
Department of Gastroenterology & Hepatology, Academic
Medical Center, University of Amsterdam, Amsterdam,
The Netherlands
123
World J Surg (2010) 34:868–869
DOI 10.1007/s00268-009-0327-5secretion, whereby each test measures a different compo-
nent of that spectrum.
In summary, criteria on the basis of which extended
liver resections are performed should preferably be dictated
by functional parameters rather than volume alone, espe-
cially when livers are resected to a minimally accepted
remnant volume. Furthermore, we advocate the use of
dynamic liver function tests such as ICG or
99mTc-me-
brofenin uptake for testing liver function due to their sen-
sitivity and prognostic strength. We acknowledge that each
of these tests reﬂects a limited aspect of liver function only.
However, currently no better, clinically viable alternatives
are available.
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